Literature DB >> 568842

Comparative in vitro effects of imipramine, oxybutynin, and flavoxate on rabbit detrusor.

C M Fredericks, R L Green, G F Anderson.   

Abstract

The ability of imipramine, oxybutynin, and flavoxate to antagonize carbamylcholine and barium chloride (BaCl2)-induced contractions of rabbit detrusor, and to block impulse conduction in desheathed frog sciatic nerves has been assessed in vitro. Impiramine exerts noncompetitive carbamylcholine and BaCl2 blockade by 10(-5) M and a local anesthetic effect equipotent with that of tetracaine. Oxybutynin exerts a strong competitive antagonism of carbamylcholine by 10(-8) M, a noncompetitive antagonism of BaCl2 equivalent to that of imipramine, and moderate local anesthetic activity. Flavoxate, under these experimental conditions exerts little anticholinergic, antispasmodis, or local anesthetic activity. Imipramine and oxybutynin thus demonstrate a number of smooth muscle effects by which their therapeutic actions may be exerted. The mechanisms of action of flavoxate remain obscure.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 568842     DOI: 10.1016/0090-4295(78)90312-6

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  The use of oxybutynin in urological practice.

Authors:  Z Kirkali; R H Whitaker
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

Review 2.  Current concepts in the treatment of disorders of micturition.

Authors:  K E Andersson
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

3.  Analysis of the anticholinergic and musculotropic effects of desmethylimipramine on the rabbit urinary bladder.

Authors:  R M Levin; D R Staskin; A J Wein
Journal:  Urol Res       Date:  1983

4.  Oxybutynin extended release for the management of overactive bladder: a clinical review.

Authors:  A M Arisco; E K Brantly; S R Kraus
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

Review 5.  Role of fesoterodine in the treatment of overactive bladder.

Authors:  Kylie J Mansfield
Journal:  Open Access J Urol       Date:  2009-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.